Characteristics of methadone maintenance treatment patients prescribed opioid analgesics

References

• Substance Abuse and Mental Health Services Administration. Results From the 2013 National Survey on Drug Use and Health: Summary of National Findings. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2014. NSDUH Series H-48, HHS Publication No. (SMA) 14–4863. http://www.samhsa.gov/data/sites/default/files/NSDUHresultsPDFWHTML2013/Web/NSDUHresults2013.pdf. Accessed August 13, 2015.
   Google Scholar
• Brands B, Blake J, Sproule B, Gourlay D, Busto U. Prescription opioid abuse in patients presenting for methadone maintenance treatment. Drug Alcohol Depend. 2004;73:199–207.
   PubMed Web of Science ®Google Scholar
• Rosenblum A, Parrino M, Schnoll SH, et al. Prescription opioid abuse among enrollees into methadone maintenance treatment. Drug Alcohol Depend. 2007;90:64–71.
   PubMed Web of Science ®Google Scholar
• Dunn KE, Sigmon SC, McGee MR, Heil SH, Higgins ST. Evaluation of ongoing oxycodone abuse among methadone-maintained patients. J Subst Abuse Treat. 2008;35:451–456.
   PubMed Web of Science ®Google Scholar
• Caviness CM, Anderson BJ, de Dios MA, Kurth M, Stein M. Prescription medication exchange patterns among methadone maintenance patients. Drug Alcohol Depend. 2013;127:232–238.
   PubMed Web of Science ®Google Scholar
• Jamison RN, Kauffman J, Katz NP. Characteristics of methadone maintenance patients with chronic pain. J Pain Symptom Manage. 2000;19:53–62.
   PubMed Web of Science ®Google Scholar
• Peles E, Schreiber S, Gordon J, Adelson M. Significantly higher methadone dose for methadone maintenance treatment (MMT) patients with chronic pain. Pain. 2005;113:340–346.
   PubMed Web of Science ®Google Scholar
• Rosenblum A, Joseph H, Fong C, Kipnis S, Cleland C, Portenoy RK. Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities. JAMA. 2003;289:2370–2378.
   PubMed Web of Science ®Google Scholar
• Compton P, Charuvastra VC, Ling W. Pain intolerance in opioid-maintained former opiate addicts: effect of long-acting maintenance agent. Drug Alcohol Depend. 2001;63:139–146.
   PubMed Web of Science ®Google Scholar
• Doverty M, White JM, Somogyi AA, Bochner F, Ali R, Ling W. Hyperalgesic responses in methadone maintenance patients. Pain. 2001;90:91–96.
   PubMed Web of Science ®Google Scholar
• Hay JL, White JM, Bochner F, Somogyi AA, Semple TJ, Rounsefell B. Hyperalgesia in opioid-managed chronic pain and opioid-dependent patients. J Pain. 2009;10:316–322.
   PubMed Web of Science ®Google Scholar
• Berg KM, Arnsten JH, Sacajiu G, Karasz A. Providers' experiences treating chronic pain among opioid-dependent drug users. J Gen Intern Med. 2009;24:482–488.
   PubMed Web of Science ®Google Scholar
• Merrill JO, Rhodes LA, Deyo RA, Marlatt GA, Bradley KA. Mutual mistrust in the medical care of drug users: the keys to the “narc” cabinet. J Gen Intern Med. 2002;17:327–333.
   PubMed Web of Science ®Google Scholar
• Jamison RN, Sheehan KA, Scanlan E, Matthews M, Ross EL. Beliefs and attitudes about opioid prescribing and chronic pain management: survey of primary care providers. J Opioid Manag. 2014;10:375–382.
   PubMedGoogle Scholar
• Substance Abuse and Mental Health Services Administration. Managing Chronic Pain in People With or in Recovery From Substance Use Disorders: A Review of the Literature. Treatment Improvement Protocol (TIP) Series 54. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2011. HHS Publication No. (SMA) 12–4671. http://store.samhsa.gov/shin/content/SMA12-4671/TIP54.pdf. Accessed August 13, 2015.
   Google Scholar
• Cunningham C. Project FIRST—Financial Incentives to Reduce Substance Use and Improve Treatment. ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01376570. Accessed August 13, 2015.
   Google Scholar
• Cunningham C. Abstinence-reinforcing contingency management to reduce HIV viral load. National Institute of Health Research Portfolio Online Reporting Tools. https://projectreporter.nih.gov/project_info_description.cfm?aid=8190763&icde=11210891&ddparam=&ddvalue=&ddsub=. Accessed August 13, 2015.
   Google Scholar
• Knisely JS, Wunsch MJ, Cropsey KL, Campbell ED. Prescription Opioid Misuse Index: a brief questionnaire to assess misuse. J Subst Abuse Treat. 2008;35:380–386.
   PubMed Web of Science ®Google Scholar
• McLellan AT, Kushner H, Metzger D, et al. The Fifth Edition of the Addiction Severity Index. J Subst Abuse Treat. 1992;9:199–213.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Alcohol Use Disorders Identification Test: Guidelines for use in Primary Care, Second Edition. Geneva, Switzerland: Department of Mental Health and Substance Dependence; 2001. http://apps.who.int/iris/bitstream/10665/67205/1/WHO_MSD_MSB_01.6a.pdf. Accessed August 13, 2015.
   Google Scholar
• American Geriatrics Society Panel on the Pharmacological Management of Persistent Pain in Older Persons. Pharmacological management of persistent pain in older persons. J Am Geriatr Soc. 2009;57:1331–1346.
   PubMed Web of Science ®Google Scholar
• Nosyk B, Fischer B, Sun H, et al. High levels of opioid analgesic co-prescription among methadone maintenance treatment clients in British Columbia, Canada: results from a population-level retrospective cohort study. Am J Addict. 2014;23:257–264.
   PubMed Web of Science ®Google Scholar
• Kurdyak P, Gomes T, Yao Z, et al. Use of other opioids during methadone therapy: a population-based study. Addiction. 2012;107:776–780.
   PubMed Web of Science ®Google Scholar
• Merrill JO. Policy progress for physician treatment of opiate addiction. J Gen Intern Med. 2002;17:361–368.
   PubMed Web of Science ®Google Scholar
• Walley AY, Farrar D, Cheng DM, Alford DP, Samet JH. Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? A patient safety issue. J Gen Intern Med. 2009;24:1007–1011.
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration. Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment Programs. Treatment Improvement Protocol (TIP) Series 43. Rockville, MD: Center for Substance Abuse Treatment; 2005. HHS Publication No. (SMA) 12-4214. http://buprenorphine.samhsa.gov/tip43_curriculum.pdf. Accessed August 13, 2015.
   Google Scholar
• Clark MR, Stoller KB, Brooner RK. Assessment and management of chronic pain in individuals seeking treatment for opioid dependence disorder. Can J Psychiatry. 2008;53:496–508.
   PubMed Web of Science ®Google Scholar
• Lucas GM, Chaudhry A, Hsu J, et al. Clinic-based treatment of opioid-dependent HIV-infected patients versus referral to an opioid treatment program: a randomized trial. Ann Intern Med. 2010;152:704–711.
   PubMed Web of Science ®Google Scholar
• Degenhardt L, Randall D, Hall W, Law M, Butler T, Burns L. Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved. Drug Alcohol Depend. 2009;105:9–15.
   PubMed Web of Science ®Google Scholar
• Shields LB, Hunsaker Iii JC, Corey TS, Ward MK, Stewart D. Methadone toxicity fatalities: a review of medical examiner cases in a large metropolitan area. J Forensic Sci. 2007;52:1389–1395.
   PubMed Web of Science ®Google Scholar